Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,579 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05479617Recruiting
Predicting ulcerative colitis flare course using personal data
This study tries to better predict how an ulcerative colitis flare will progress by using a mix of your medical information. If you are eligible, your flare details may help researchers build tools that guide future care.
Hvidovre, DenmarkAges 18 years+ - NCT06062017Recruiting
Potassium, hydration, and heart health in young adults
This study looks at how potassium and hydration affect heart and kidney health in healthy young adults. It may help you understand your own health and contribute to new knowledge about preventing disease.
Auburn, AlabamaAges 18–30 - NCT06580418Recruiting
Study of an anti-TREM-1 drug in a gut model
This trial tests a new drug that blocks a protein called TREM-1, which may help reduce inflammation in the gut. It uses tissue samples from people with active ulcerative colitis or Crohn's disease to see if the drug is effective.
MilanAges 18–60 - NCT07355413Recruiting
Frailty and health in older adults with HIV in West Africa
This study looks at how frailty (weakness) and other age-related health issues affect older adults living with HIV in West Africa. By comparing those with and without HIV, researchers hope to better understand the care needs of this group.
Bobo-DioulassoAges 60 years+ - NCT07354269RecruitingPhase 4
Polio vaccine study for adolescents and adults
This trial tests a polio vaccine (sIPV) in healthy people aged 7-50 years. It aims to see how safe and effective the vaccine is, and may help protect against polio.
Dingxi, GansuAges 3 months–50 years - NCT07357428Recruiting
Brain-computer implant study for severe paralysis or speech loss
This study tests a brain-computer implant that might help people with severe paralysis or speech loss control a computer with their thoughts. It is for people who have trouble moving and speaking due to a progressive disease or injury.
Sacramento, CaliforniaAges 22–75 - NCT07355218RecruitingPhase 3
Testing enpatoran for lupus skin problems
This trial tests an oral drug called enpatoran for people with lupus that causes skin rashes (like discoid or subacute cutaneous lupus). The goal is to see if the drug can improve these skin symptoms.
Upland, CaliforniaAges 18–75 - NCT07358546RecruitingPhase 1
Test of efimosfermin alfa in adults with liver problems
This trial is for adults with liver cirrhosis (scarring) who have moderate to severe liver impairment. It studies how the body handles a new medicine called efimosfermin alfa, to see if it could be a safe treatment option. You may be able to join if your liver function is stable and you fall into a specific Child-Pugh class.
Rialto, CaliforniaAges 18–70 - NCT07356713RecruitingPhase 1
Finding the right dose of EXL-111 for healthy volunteers
This trial tests a new drug called EXL-111 in healthy people to find the safest and best dose for future studies. It may help people with allergies if the drug proves effective.
Adelaide, South AustraliaAges 18–55 - NCT06848959Recruiting
Better diagnosis and treatment for children's brain conditions
This study is building a smarter way to diagnose and treat brain conditions in children, such as cerebral palsy, ADHD, and autism. It uses advanced computer models to help doctors provide better care.
NanjingAges 2–18 - NCT07354347Recruiting
Finding the best pace settings for ICDs
This trial studies how to set the pacemaker function in an implantable cardioverter-defibrillator (ICD) to stop dangerous heart rhythms more effectively. It may help you if you have an ICD for preventing or treating fast heartbeats.
Copenhagen, Dr.Ages 18 years+ - NCT07355452Enrolling by invitation
Leg closure after heart bypass vein harvesting
This trial compares two ways of closing the leg after doctors remove a vein for heart bypass surgery. The goal is to see which method leads to better healing and fewer complications.
Karachi, SindhAges 18–70 - NCT07360899Recruiting
Closing the left atrial appendage during heart surgery to prevent stroke
This trial tests if closing the left atrial appendage with a special stitch during planned heart surgery can help prevent strokes in people with atrial fibrillation. If you already need heart surgery, this extra step may reduce your future stroke risk.
Kamenitz, VojvodinaAges 18 years+ - NCT07354048Recruiting
Thyroid health and its effect on liver function
This study looks at how thyroid problems (both overactive and underactive) may affect liver function tests. It aims to help researchers understand the link between thyroid and liver health.
SohagAges 20–60 - NCT07355842Recruiting
Can slow brain waves slow Parkinson's?
This study tests whether playing soft sounds during deep sleep can slow down brain changes in people with REM sleep behavior disorder (a condition linked to Parkinson's disease). It is for people who have this sleep disorder or were recently diagnosed with Parkinson's, and are not yet on Parkinson's medications.
Zurich, Canton of ZurichAges Any age - NCT07361055Enrolling by invitation
Heart ablation study using no X-ray
This trial tests a new way to treat a fast heart rhythm called PSVT using a procedure that avoids X-ray radiation. It aims to see if this approach is safer and works well for patients who need this treatment.
TaipeiAges 18 years+ - NCT07356245RecruitingPhase 2
Ruxolitinib after stem cell transplant for T-cell lymphoma
This trial tests whether taking ruxolitinib after a stem cell transplant can help prevent T-cell lymphoma from coming back. It is for patients whose lymphoma is in remission (partial or complete) after their transplant.
Columbus, OhioAges 18 years+ - NCT07358572Recruiting
Eye-brain-kidney study in chronic kidney disease
This study is looking at how chronic kidney disease (CKD) affects the eyes, brain, and kidneys. It uses MRI scans to examine these organs, and aims to find connections that could help improve care for people with CKD.
Beijing, Beijing MunicipalityAges 18–70 - NCT07353255Recruiting
Comparing two tools for nose breathing tube placement
This trial compares two methods (fibrescope vs videolaryngoscope) for placing a breathing tube through the nose during surgery. It aims to find which technique is easier and safer for patients like you.
Coventry, West MidlandsAges 18 years+ - NCT07358832Recruiting
Brain stimulation for vision loss after recent brain injury
This trial tests whether combining brain stimulation with visual exercises can help improve vision loss caused by a recent brain injury. It is designed for people in the early recovery phase (within 3 months of injury) who have visual field deficits, but not other conditions like neglect or eye movement problems.
Milan, LombardyAges 18 years+ - NCT07359430Recruiting
Deep phenotyping of chronic inducible urticaria
This study aims to better understand inducible urticaria (hives triggered by cold, pressure, or friction) and chronic spontaneous urticaria. Researchers will use skin tests to measure how different triggers affect your skin in detail.
Leiden, South HollandAges 18 years+ - NCT07355335RecruitingPhase 1
Study of two targeted drugs for leukemia with certain genetic changes
This study tests a combination of two medications, ziftomenib and mezigdomide, for people with acute myeloid leukemia (AML) that has come back or not responded to treatment. It is specifically for patients whose leukemia cells have a particular genetic change, which the drugs are designed to target.
Boston, MassachusettsAges 12 years+ - NCT07360886Recruiting
Early detection of brain conditions in active drivers
This study looks at how well doctors can spot early signs of certain brain conditions in people who drive. You may join if you have a valid license, are between 18 and 85, and have one of the neurological diagnoses the study is focusing on.
Olomouc, Olomouc RegionAges 18–85 - NCT07352852Recruiting
Rapamycin-coated stent for narrowed brain arteries
This study tests a special stent that slowly releases a drug (rapamycin) to keep a narrowed brain artery open. It is for patients who have had strokes despite medical treatment.
Qingdao, ShandongAges 18–80
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,579 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.